2022 annual financial data
Purple Biotech Ltd. 2022 Operating margin
Purple Biotech Ltd. 2022 operating margin with verified reported values.
Direct answer
Operating margin was 2,483.85%.
Operating income was -22,603,000 USD and net income was -21,668,000 USD.
Operating cash flow was -16,735,000 USD.
Get free Purple Biotech Ltd. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -910,000 USD
- Operating income
- -22,603,000 USD
- Net income
- -21,668,000 USD
- Operating cash flow
- -16,735,000 USD